ClinicalTrials.Veeva

Menu

Impact of Surgical Management for Relapse After Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastasis

Fudan University logo

Fudan University

Status

Completed

Conditions

Liver Metastases
Colorectal Cancer

Treatments

Procedure: Non-Repeat Liver Surgery
Procedure: Repeat Liver Surgery

Study type

Observational

Funder types

Other

Identifiers

NCT05462470
IU-CRLM

Details and patient eligibility

About

For patients with initially unresectable colorectal liver metastasis (IU-CRLM) receiving effective conversion therapy, disease relapse after conversion hepatectomy is common due to the extensive tumor load. Yet, few studies have focused on the assessment and management of relapse after conversion hepatectomy for IU-CRLM. This study aimed to investigate the impact of surgical management for relapse after conversion hepatectomy in IU-CRLM.

Enrollment

255 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • initially unresectable colorectal liver metastasis (IU-CRLM)
  • received conversion therapy
  • underwent conversion hepatectomy

Exclusion criteria

  • the histologic type of CRLM was not called adenocarcinoma
  • uncontrollable extrahepatic metastases, such as peritoneal, bone, brain metastasis
  • history of previous hepatectomy
  • the primary tumor was not resected or palliative resection
  • R1 or R2 liver resection

Trial design

255 participants in 2 patient groups

repeat liver surgery
Description:
repeat liver surgery for liver relapse lesions
Treatment:
Procedure: Repeat Liver Surgery
non-repeat liver surgery
Description:
non-repeat liver surgery, just only systemic palliative chemotherapy
Treatment:
Procedure: Non-Repeat Liver Surgery

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems